Timothy Hanlon

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer”.

PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer

npj Precision Oncology(2022)10.1038/s41698-022-00291-7

N/A

0DataRank · unranked

27 citations

Raie Bekele, Zsofia Sztupinszki, Timothy Hanlon, Shahrzad Rafiei, Zoltán Szállási +3 more

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

Scientific Reports(2023)10.1038/s41598-023-47946-4

N/A

0DataRank · unranked

9 citations

Haohui Duan, Viktória Tisza, Pranshu Sahgal, Sabine Topka, Gregory T. Klus +17 more

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.07.527498

N/A

0DataRank · unranked

2 citations

Haohui Duan, Viktória Tisza, Pranshu Sahgal, Sabine Topka, Gregory T. Klus +17 more